Anthony J. Maddaluna, Director at Intec Pharma Ltd. (NTEC), bought 25,000 shares at $0.47 ($12K) on 2019-08-27, disclosed to the SEC on 2019-08-29.
High-signal trade — passes our conviction filters but the AI narrative is still being generated. Check back shortly.
Clearly above the average filing.
| Filing → |
| PFE | SELL | 2016-05-11 | $604K | — | Filing → |
| PFE | SELL | 2015-02-13 | $314K | — | Filing → |
| PFE | SELL | 2015-02-11 | $304K | — | Filing → |